Pulike Biological Engineering, Inc. (603566.SS) SHH

Currency In CNY

AD

Valuation

Market Cap4.26B
Enterprise Value4.18B
P/E Ratio20.68
PEG Ratio0.48
Price/Sales Ratio3.34
Price/Book Ratio1.33
Enterprise/Revenue3.31
Enterprise/EBITDA13.52

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.16
Operating Margin0.16
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.07

Income Statement

Revenue1.09B
Revenue/Share3.12
Gross Profit652.53M
EBITDA329.88M
Net Income184.99M
Diluted EPS0.54

Balance Sheet

Total Cash754.34M
Total Cash/Share2.22
Total Debt55.44M
Total Debt/Equity0.02
Current Ratio3.82
Book Value Per Share8.17

Price History

52-Week Change-22.21
52-Week High15.79
52-Week Low9.65
Moving Average 50 Days11.38
Moving Average 200 Days12.98

Statistics

Average Volume3.51M
Shares Outstanding341.92M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.6
Trailing Annual Dividend Yield5.79
Payout Ratio1.19
Last Split Factor2:1
Last Split DateMay 31, 2016
AD